New Findings Suggest No Correlation Between GLP-1 Receptor Agonists and Thyroid Cancer Risk
A recent study examined whether glucagon-like peptide (GLP)-1 receptor agonists are associated with an increased risk of thyroid cancer.
A recent study examined whether glucagon-like peptide (GLP)-1 receptor agonists are associated with an increased risk of thyroid cancer.
Relapsed or refractory acute myeloid leukemia (AML) has an extremely poor prognosis because of intrinsic chemotherapy resistance and high rates of relapse,
Prostate Cancer UK has today announced details of a £42 million screening trial, which aims to find the best way to screen men for prostate…
This article evaluates the clinical outcomes of etoposide and cytarabine consolidation chemotherapy following high-dose methotrexate-based induction chemot
This cohort study evaluates the association between bilateral oophorectomy and all-cause mortality among women with BRCA1 or BRCA2 sequence variations.
This cohort study assesses the association of functional laryngectomy with self-perceptions of voice, swallowing, oral intake, quality of life, and mood among survivors of head…
Kenneth C. Anderson, MD, discusses the recent ODAC decisions for ide-cel and cilta-cel, highlighting clinical trial data supporting the indications.
Join us for an exciting discussion where expert oncologists in the field of colorectal cancer will deliberate on nuances related to sequencing oral tyrosine kinase…
Vebreltinib has received approval from China’s NMPA in pretreated IDH-mutant, PTPRZ1-MET fusion–positive astrocytoma or glioblastoma.
Bill Grambley explains how his company attacks health inequalities by providing personalized pharmaceutical care with an AI based platform.
We have noticed an unusual activity from your IP 192.133.77.15 and blocked access to this